• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例对照研究中用于罕见变异选择的逐步似然比检验程序。

A stepwise likelihood ratio test procedure for rare variant selection in case-control studies.

作者信息

Kuk Anthony Y C, Nott David J, Yang Yaning

机构信息

Department of Statistics and Applied Probability, National University of Singapore, Singapore, Singapore.

Department of Statistics and Finance, University of Science and Technology, Hefei, China.

出版信息

J Hum Genet. 2014 Apr;59(4):198-205. doi: 10.1038/jhg.2014.1. Epub 2014 Jan 23.

DOI:10.1038/jhg.2014.1
PMID:24451226
Abstract

There is much recent interest in finding rare genetic variants associated with various diseases. Owing to the scarcity of rare mutations, single-variant analyses often lack power. To enable pooling of information across variants, we use a random effect formulation within a retrospective modeling framework that respects the retrospective data collecting mechanism of case-control studies. More concretely, we model the control allele frequencies of the variants as random effects, and the systematic differences between the case and control frequencies as fixed effects, resulting in a mixed model. The use of Poisson approximation and gamma-distributed random effects results in a generalized negative binomial distribution for the joint distribution of the control and case frequencies. Variants are selected by conducting stepwise likelihood ratio tests. The superiority of the proposed method over two existing variant selection methods is demonstrated in a simulation study. The effects of non-gamma random effects and correlated variants are also found to be not too detrimental in the simulation study. When the proposed procedure is applied to identify rare variants associated with obesity, it identifies one additional variant not picked up by existing methods.

摘要

近期,人们对寻找与各种疾病相关的罕见基因变异有着浓厚兴趣。由于罕见突变的稀缺性,单变异分析往往缺乏效力。为了能够汇总各变异的信息,我们在一个回顾性建模框架内采用随机效应公式,该框架尊重病例对照研究的回顾性数据收集机制。更具体地说,我们将变异的对照等位基因频率建模为随机效应,病例和对照频率之间的系统差异建模为固定效应,从而得到一个混合模型。泊松近似和伽马分布随机效应的使用导致对照和病例频率的联合分布呈现广义负二项分布。通过进行逐步似然比检验来选择变异。在一项模拟研究中证明了所提出方法相对于两种现有变异选择方法的优越性。在模拟研究中还发现,非伽马随机效应和相关变异的影响并非过于有害。当将所提出的程序应用于识别与肥胖相关的罕见变异时,它识别出了现有方法未发现的一个额外变异。

相似文献

1
A stepwise likelihood ratio test procedure for rare variant selection in case-control studies.病例对照研究中用于罕见变异选择的逐步似然比检验程序。
J Hum Genet. 2014 Apr;59(4):198-205. doi: 10.1038/jhg.2014.1. Epub 2014 Jan 23.
2
Weighted Score Tests Implementing Model-Averaging Schemes in Detection of Rare Variants in Case-Control Studies.在病例对照研究中检测罕见变异时实施模型平均方案的加权评分检验。
PLoS One. 2015 Oct 5;10(10):e0139355. doi: 10.1371/journal.pone.0139355. eCollection 2015.
3
Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level.对两个内源性大麻素代谢基因进行人群测序,鉴定出与极端肥胖和代谢物水平相关的罕见和常见调控变异。
Genome Biol. 2010;11(11):R118. doi: 10.1186/gb-2010-11-11-r118. Epub 2010 Nov 30.
4
Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?大麻素CB1受体拮抗剂利莫那班是否正在推动肥胖症的治疗?
Expert Opin Pharmacother. 2005 Oct;6(12):2141-4. doi: 10.1517/14656566.6.12.2141.
5
An EM algorithm based on an internal list for estimating haplotype distributions of rare variants from pooled genotype data.基于内部列表的 EM 算法,用于从合并基因型数据估计罕见变异体的单体型分布。
BMC Genet. 2013 Sep 13;14:82. doi: 10.1186/1471-2156-14-82.
6
Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors.利莫那班:一种用于治疗肥胖、戒烟及心血管代谢危险因素的大麻素CB1受体选择性阻滞剂。
Expert Opin Investig Drugs. 2006 Mar;15(3):307-15. doi: 10.1517/13543784.15.3.307.
7
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.大麻素-1受体阻滞剂利莫那班对超重患者体重减轻及心血管危险因素的影响:来自欧洲RIO研究的1年经验
Lancet. 2005;365(9468):1389-97. doi: 10.1016/S0140-6736(05)66374-X.
8
Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant?新型CB1大麻素受体拮抗剂SR-147778会比利莫那班更具优势吗?
Expert Opin Investig Drugs. 2005 Mar;14(3):339-42. doi: 10.1517/13543784.14.3.339.
9
Update on rimonabant--a selective cannabinoid CB1 antagonist.利莫那班——一种选择性大麻素CB1拮抗剂的最新情况
Ann Pharmacother. 2006 May;40(5):994. doi: 10.1345/aph.1G713. Epub 2006 Apr 25.
10
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity.利莫那班在随机对照试验中的代谢作用概述:其他大麻素 1 型受体阻滞剂在肥胖症中的应用潜力。
J Clin Pharm Ther. 2011 Feb;36(1):10-8. doi: 10.1111/j.1365-2710.2010.01164.x.

引用本文的文献

1
A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.一种用于孟德尔疾病致病性评估的标准化DNA变异评分系统。
Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.
2
Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.评估顺铂/培美曲塞化疗对肺腺癌患者治疗效果的预后模型的开发与交叉验证
Med Oncol. 2014 Sep;31(9):59. doi: 10.1007/s12032-014-0059-8. Epub 2014 Aug 14.

本文引用的文献

1
Analysis and optimal design for association studies using next-generation sequencing with case-control pools.使用病例对照样本池的新一代测序进行关联研究的分析与优化设计
Genet Epidemiol. 2012 Dec;36(8):870-81. doi: 10.1002/gepi.21681. Epub 2012 Sep 12.
2
A fast collapsed data method for estimating haplotype frequencies from pooled genotype data with applications to the study of rare variants.一种快速的崩溃数据方法,用于从合并基因型数据中估计单倍型频率,应用于稀有变异体的研究。
Stat Med. 2013 Apr 15;32(8):1343-60. doi: 10.1002/sim.5540. Epub 2012 Aug 1.
3
A general framework for detecting disease associations with rare variants in sequencing studies.
一种用于在测序研究中检测罕见变异与疾病关联的通用框架。
Am J Hum Genet. 2011 Sep 9;89(3):354-67. doi: 10.1016/j.ajhg.2011.07.015. Epub 2011 Sep 1.
4
Rare-variant association testing for sequencing data with the sequence kernel association test.基于序列核关联检验的测序数据罕见变异关联分析
Am J Hum Genet. 2011 Jul 15;89(1):82-93. doi: 10.1016/j.ajhg.2011.05.029. Epub 2011 Jul 7.
5
Testing for an unusual distribution of rare variants.检测罕见变异的异常分布。
PLoS Genet. 2011 Mar;7(3):e1001322. doi: 10.1371/journal.pgen.1001322. Epub 2011 Mar 3.
6
Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level.对两个内源性大麻素代谢基因进行人群测序,鉴定出与极端肥胖和代谢物水平相关的罕见和常见调控变异。
Genome Biol. 2010;11(11):R118. doi: 10.1186/gb-2010-11-11-r118. Epub 2010 Nov 30.
7
Comprehensive approach to analyzing rare genetic variants.综合分析罕见遗传变异。
PLoS One. 2010 Nov 3;5(11):e13584. doi: 10.1371/journal.pone.0013584.
8
A covering method for detecting genetic associations between rare variants and common phenotypes.一种用于检测罕见变异与常见表型之间遗传关联的覆盖方法。
PLoS Comput Biol. 2010 Oct 14;6(10):e1000954. doi: 10.1371/journal.pcbi.1000954.
9
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.利莫那班预防心血管事件(CRESCENDO):一项随机、多中心、安慰剂对照试验。
Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X.
10
Design of association studies with pooled or un-pooled next-generation sequencing data.基于汇集或未汇集下一代测序数据的关联研究设计。
Genet Epidemiol. 2010 Jul;34(5):479-91. doi: 10.1002/gepi.20501.